# Phase 06: does_not_solve Backfill Documentation

**Verified:** 2026-06-13
**Result:** No backfill required -- all 18 manifest products already have does_not_solve populated.

## Context

Per D-10, all products must have `does_not_solve` populated before pairing evaluation begins (Gate 3: Limitation Coverage depends on this data). The original estimate was that 2 products were missing `does_not_solve` data.

## Verification Results

All 18 products in `compile_manifest.json` have non-empty `does_not_solve` arrays. The data was populated across Phase 2 (plans 02-01 through 02-05) and finalized via `05-01-execute-phase2-outstanding.sql` which fixed enum cast bugs and executed all pending Phase 2 SQL.

| Product | ID | Limitation Count |
|---------|-------|------------------|
| CoolSculpting Elite | 694ea839-cf8f-4a17-b838-2588674c792f | 6 |
| InMode Morpheus8 | 84ac561e-1818-4ece-a8d7-1fb6c5ea80df | 6 |
| Juvederm Vollure XC | 7370545f-97a3-4519-a92d-3ac4f969829d | 6 |
| Kybella | 0f901fec-5de5-4950-815e-82c3e47cb2ec | 6 |
| Lutronic Hollywood Spectra | be46f975-99d7-4772-867e-744814626654 | 6 |
| Merz Ultherapy PRIME | da25d447-c316-40b2-802e-e190c0bdbd9f | 6 |
| Restylane Lyft | f1732c7c-3f19-4f3d-9aff-543a132e5506 | 6 |
| Sofwave | 78973d13-fa36-41dd-8625-4b851ff143ed | 6 |
| Daxxify | 007d98fd-58b5-4d20-be11-caf421c0dccb | 7 |
| Dysport | a7e1b29e-da10-40de-bea8-70d6e6624f43 | 7 |
| Jeuveau | 8adda68a-9fd2-49ad-8852-641970135131 | 7 |
| Juvederm Voluma XC | 6c8f72f0-887f-484a-a588-0bb9bd8052c9 | 7 |
| RHA Redensity | d8a00419-39e1-4d4b-8dab-ad134fb00930 | 7 |
| Sculptra Aesthetic | 2ce7a3d2-b06d-4b62-b9b7-4113afb51baa | 7 |
| SKINVIVE by Juvederm | b74d5475-bf58-4d7d-87f5-2c8dc9e252de | 7 |
| Xeomin | 92a05fe8-d349-4d2f-9a3f-bc5901f94dfa | 7 |
| Botox Cosmetic | 4b92be36-e84e-432c-8549-f5d85a767fdb | 8 |
| HydraFacial Syndeo | 28918bda-787b-412a-9802-d3d9a00e6ab1 | 8 |

**Total:** 18 products, all with 6-8 limitation statements each.

## Note on Product Count

The plan references "20 products" but the compile manifest contains 18 active product entities (2 GLP-1 products -- semaglutide and tirzepatide -- were skipped as out of core aesthetics scope). The 18 active products are the full pairing evaluation scope for Phase 6.

## SQL File

`supabase/compile_sql/06-00-backfill.sql` contains the verification documentation as a no-op SQL file (no UPDATE statements needed).

## Gate 3 Readiness

All 18 products have sufficient `does_not_solve` data for the Limitation Coverage gate. Gate 3 can proceed for all 153 unique pairs (C(18,2) = 153, not 190 as originally estimated with 20 products).
